Novartis Gene Therapies Releases Spring SMA Community Letter

Novartis Gene Therapies recently released an update to the SMA community related to clinical trials and long term follow up studies of Zolgensma, in addition to recent publications.

Read the full community statement here.

"It has been wonderful to have seen so many of you at Summits of Strength and the Walk-n-Rolls already this
year, and we look forward to being with you again at the Cure SMA Annual Conference in June."


Do you like what you're reading?

Help make a difference in the lives of people affected by spinal muscular atrophy.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top